Moderna (MRNA) Reports In-Line Q1 EPS

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $17.09 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Royal Unibrew reports higher interim first-half profit as margins improve
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell